ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

IFRX InflaRx NV

1.35
-0.03 (-2.17%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
InflaRx NV IFRX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.03 -2.17% 1.35 07:00:02
개장가 저가 고가 종가 전일 종가
1.40 1.28 1.4492 1.36 1.38
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202420:30GLOBEInflaRx to Host Virtual R&D Event on June 5, 2024 and..
24/04/202420:30GLOBEInflaRx to Participate in Capital One Securities 1st Annual..
21/03/202420:00GLOBEInflaRx Reports Full Year 2023 Results and Announces INF904..
19/03/202420:30GLOBEInflaRx to Announce Development Plans for INF904 and 2023..
22/02/202421:30GLOBEInflaRx Appoints Jan Medina as Head of Investor Relations
25/01/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/01/202421:30GLOBEInflaRx Announces Initiation of its Commitment Program for..
05/01/202406:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/01/202421:00GLOBEInflaRx Announces Positive Topline Results from the Multiple..
06/11/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202321:30GLOBEInflaRx Announces First Patient Dosed in Phase III Trial..
01/11/202321:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202320:30GLOBEInflaRx Reports Third Quarter 2023 Financial Results and..
11/09/202321:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/09/202320:00GLOBEInflaRx Announces Positive Topline Results from the Single..
30/08/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/08/202320:30GLOBEInflaRx’s Marketing Authorization Application (MAA) for..
10/08/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/08/202320:30GLOBEInflaRx Reports Second Quarter 2023 Financial Results &..
13/07/202305:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/07/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
01/07/202305:06EDGAR2Form F-3 - Registration statement by foreign private issuers
28/06/202321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/06/202320:30GLOBEInflaRx Appoints Dr. Camilla Chong as Chief Medical Officer
21/06/202320:00GLOBEInflaRx Announces Commercial Launch of Gohibic (vilobelimab)..
11/05/202320:30GLOBEInflaRx Reports First Quarter 2023 Financial and Operating..

최근 히스토리

Delayed Upgrade Clock